Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.945 USD | -0.92% | +7.59% | +63.46% |
22/06 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
29/05 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.46% | 163.39Cr | |
+18.01% | 13TCr | |
+23.04% | 12TCr | |
+23.26% | 2.79TCr | |
-18.48% | 2.1TCr | |
-15.13% | 1.69TCr | |
-15.69% | 1.62TCr | |
+9.30% | 1.48TCr | |
-46.10% | 1.48TCr | |
+52.38% | 1.41TCr |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Transcript : MannKind Corp. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 07